Zoommed Inc (ZMMDF) 0.0370 $ZMMDF
ZoomMed Signs an Agreement with Desjardins Insurance, the First Insurer in Canada to Work with an Electronic Prescriber
Marketwire - Tue Feb 18, 7:48AM CST
ZoomMed Inc. (TSX VENTURE: ZMD) (the "Company" or "ZoomMed"
is pleased to announce that it has signed an agreement with Desjardins Insurance for the development and operation of a project focusing for a web-based solution to integrate selected insurance plan information into the ZRx Prescriber to provide physician users with information while they are entering prescriptions on their PC, tablet or smartphone.
ZoomMed Announces the Closing of a New Financing and the Repayment of its $1,5M Convertible Debenture
Marketwire - Thu Jan 16, 4:32PM CST
ZoomMed Inc. (TSX VENTURE: ZMD) (the "Corporation" announces the closing of a non-revolving loan, for a principal amount not exceeding US$2,000,000 (the "Loan", of which US$1,664,318.92 has already been advanced, and the repayment of the CA$1,500,000 current convertible debenture.
Annual and Special Shareholders Meeting of ZoomMed Inc.
Marketwire - Fri Nov 29, 11:02AM CST
ZoomMed Inc. (TSX VENTURE: ZMD), announces it has held its Annual and Special Meeting of Shareholders as at November 29, 2013.
ZoomMed Announces a Financing and the Issuance of Shares
Marketwire - Thu Nov 14, 3:44PM CST
ZoomMed Inc. (TSX VENTURE: ZMD) (the "Company" or "ZoomMed" announces it has signed a term sheet with regards to a four million dollar ($4,000,000) non-convertible debenture financing, subject to due diligence with a Toronto-based investment firm. Subject to the approval of the TSX Venture Exchange and the regulatory authorities, ZoomMed will issue to MSU Securities Law Professional Corporation ("MSU" five hundred and eight thousand seven hundred and eighty-six (508,786) common shares of the Company at a deemed price of five cents ($0.05) per common share, as compensation for legal due diligence services rendered within the scope of the financing. ZoomMed deals at arm's length with MSU.
ZoomMed Signs a US$3.5M Exclusive License Agreement for the Distribution and Licensing of the ZRx Prescriber in the U.S Market
Marketwire - Thu Apr 25, 8:47AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD), is very pleased to announce the signature of an Exclusive License Agreement regarding the rights to distribute, license and sub-license the ZRx Prescriber in the United States for a consideration of more than US$ 3.5M, with EvEMR Inc., a Washington D.C. based company.
ZoomMed: ZRx Prescriber Soon Available for Download on the "App Store"
Marketwire - Thu Feb 07, 9:00AM CST
ZoomMed inc. (TSX VENTURE: ZMD), is proud to announce the ZRx Prescriber will soon be available for download on the "App Store" by all potential users throughout North America.
ZoomMed Signs an Agreement with Desjardins Insurance, the First Insurer in Canada to Work with an Electronic Prescriber
Marketwire - Tue Feb 18, 7:48AM CST
ZoomMed Inc. (TSX VENTURE: ZMD) (the "Company" or "ZoomMed"
is pleased to announce that it has signed an agreement with Desjardins Insurance for the development and operation of a project focusing for a web-based solution to integrate selected insurance plan information into the ZRx Prescriber to provide physician users with information while they are entering prescriptions on their PC, tablet or smartphone. ZoomMed Announces the Closing of a New Financing and the Repayment of its $1,5M Convertible Debenture
Marketwire - Thu Jan 16, 4:32PM CST
ZoomMed Inc. (TSX VENTURE: ZMD) (the "Corporation"
announces the closing of a non-revolving loan, for a principal amount not exceeding US$2,000,000 (the "Loan", of which US$1,664,318.92 has already been advanced, and the repayment of the CA$1,500,000 current convertible debenture. Annual and Special Shareholders Meeting of ZoomMed Inc.
Marketwire - Fri Nov 29, 11:02AM CST
ZoomMed Inc. (TSX VENTURE: ZMD), announces it has held its Annual and Special Meeting of Shareholders as at November 29, 2013.
ZoomMed Announces a Financing and the Issuance of Shares
Marketwire - Thu Nov 14, 3:44PM CST
ZoomMed Inc. (TSX VENTURE: ZMD) (the "Company" or "ZoomMed"
announces it has signed a term sheet with regards to a four million dollar ($4,000,000) non-convertible debenture financing, subject to due diligence with a Toronto-based investment firm. Subject to the approval of the TSX Venture Exchange and the regulatory authorities, ZoomMed will issue to MSU Securities Law Professional Corporation ("MSU" five hundred and eight thousand seven hundred and eighty-six (508,786) common shares of the Company at a deemed price of five cents ($0.05) per common share, as compensation for legal due diligence services rendered within the scope of the financing. ZoomMed deals at arm's length with MSU. ZoomMed Signs a US$3.5M Exclusive License Agreement for the Distribution and Licensing of the ZRx Prescriber in the U.S Market
Marketwire - Thu Apr 25, 8:47AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD), is very pleased to announce the signature of an Exclusive License Agreement regarding the rights to distribute, license and sub-license the ZRx Prescriber in the United States for a consideration of more than US$ 3.5M, with EvEMR Inc., a Washington D.C. based company.
ZoomMed: ZRx Prescriber Soon Available for Download on the "App Store"
Marketwire - Thu Feb 07, 9:00AM CST
ZoomMed inc. (TSX VENTURE: ZMD), is proud to announce the ZRx Prescriber will soon be available for download on the "App Store" by all potential users throughout North America.
